To view the PDF file, sign up for a MySharenet subscription.

NTC - Netcare Limited - Unaudited Group interim results for the six months

Release Date: 16/05/2011 07:05
Code(s): NTC
Wrap Text

NTC - Netcare Limited - Unaudited Group interim results for the six months ended 31 March 2011 Netcare Limited "Netcare", "the Company" or "the Group" Registration number: 1996/008242/06 (Incorporated in the Republic of South Africa) JSE share code: NTC ISIN code: ZAE000011953 Unaudited Group interim results for the six months ended 31 March 2011 Basic headline earnings per share (cents) 2011: 48.0 cents 2010: 41.5 cents Free cash flow (Rm) 2011: R1 586 million 2010: R1 264 million Distributions per share (cents) 2011: 22.0 cents 2010: 19.0 cents Commentary Group financial review Overview For the six months ended 31 March 2011, earnings attributable to shareholders increased by 15.0% to R666 million from R579 million in the prior year. Headline earnings per share (HEPS) increased by 15.7% to 48.0 cents. A strong performance in South Africa (SA) offset weaker results in the United Kingdom (UK), which were negatively impacted by the challenging economic environment. The Group continued to focus on operational efficiency, cost containment and the implementation of business improvement plans to support robust and sustainable businesses. Netcare`s financial position is underpinned by strong cash generation with free cash flow increasing by 25.5% from the prior year. Financial performance In the respective local currencies, revenue grew in SA and the UK. On a constant currency basis, Group revenue rose by 7.1% compared to the same period last year, while reported revenue increased 3.2% to R11 392 million (2010: R11 038 million). Group operating profit decreased by 7.9% to R1 698 million (2010: R1 843 million). Currency conversion accounted for 3.0% of this reduction with the balance largely attributable to lower profits in the UK. Net financial expenses decreased by R57 million to R948 million, driven by strong cash generation in SA and the UK, reduced interest rates in SA and a lower average exchange rate on UK borrowing costs. Financial expenses were negatively affected by a R61 million non-cash charge, representing the ineffective portion of the fair value adjustment on the interest rate swaps for the period. The interest rate swaps are hedge accounted and fair value adjustments are recognised directly in equity to the extent that the hedging is effective. Group taxation of R54 million, represents an effective tax rate of 7.2%. This arises from the favourable impact of a deferred tax release of R155 million in the UK, following a further 1% reduction in the UK tax rate to 26%. Excluding the impact of the rate change, the Group`s effective tax rate was 27.8%. Financial position and cash flow Net debt reduced to R23 838 million (R24 197 million at 30 September 2010), due to a lower closing exchange rate and debt repayments in the UK. Equity increased by R1 484 million from 30 September 2010. This was mainly due to favourable non-cash mark-to-market fair value adjustments on the UK interest rate swaps recognised in the cash flow hedge accounting reserve, as well as profit of R699 million for the period. Free cash flow improved by 25.5% to R1 586 million (2010: R1 264 million) reflecting the Group`s focus on cash generation. During the period, capital expenditure including intangible assets, of R461 million (2010: R449 million) was invested to ensure that future demand for services can be met. Capital expenditure of R1 433 million had been committed at 31 March 2011. Divisional review South Africa Revenue grew 7.6% to R6 472 million from R6 014 million, and operating profit rose 20.3% to R1 021 million (2010: R849 million). The operating profit margin improved from 14.1% to 15.8%. The SA operations contributed 95.2% (2010: 86.5%) to basic HEPS. Cash generated in SA increased by 28.6% to R949 million (2010: R738 million), bolstered by exceptional inventory and trade receivables management. Capital expenditure including intangible assets was R242 million (2010: R278 million) of which R142 million was spent on expanding our operations. Netcare won the Metropolitan Oliver Empowerment Awards for Top Empowered Company of the Year, Top Empowered Big Business and Healthcare and Pharmaceuticals sector. In the Financial Mail`s Top Empowerment Companies Survey for 2011, Netcare was ranked the most empowered company in the JSE`s healthcare sector for the third year in a row. Netcare was also named a Level 1 Gold Community Contributor by the National Department of Social Development, recognising our commitment to uplifting the communities in which we operate. Accelerating transformation is one of Netcare`s strategic pillars and it is humbling to be recognised among SA`s best companies for our progress in this regard. We are pleased to advise that on 24 March 2011 the JSE Limited and SRI Index Advisory Committee reinstated Netcare to the SRI Index for 2011. This followed representations by the Company to the JSE regarding the organ transplant matter. Netcare is committed to good corporate governance as the foundation for building trust among all our stakeholders. The Board has adopted the governance principles espoused by the Code of Corporate Practices (King Code) and has undertaken a thorough review of the revised King Code (King III). Enhanced sustainability is a key strategic imperative for Netcare`s executive committee. It is supported by a dedicated Sustainability Committee, which manages our efforts to embed sustainability principles into our daily business practices. The disclosure of material sustainability issues and performance against appropriate key performance indicators in Netcare`s Integrated Report for the year ending 30 September 2011, will be overseen by the Board and relevant committees. Hospitals and Emergency services Revenue from Hospitals and Emergency services grew 9.5% to R5 844 million (2010: R5 336 million), and EBITDA rose 15.7% to R1 191 million (2010: R1 029 million). The division grew patient days by 2.8%, with a 6.7% increase in net revenue per patient day. The Hospital division continued to invest in infrastructure. We upgraded the existing catheterisation laboratory at Netcare Sunward Park Hospital to a new hybrid catheterisation theatre for cardiac and general vascular procedures. This enables less invasive procedures leading to faster results, reduced hospitalisation and significant cost savings. It utilises the latest in robotic technology to improve treatment capabilities. Operating theatres at Netcare Parklane and Garden City hospitals were renovated and the paediatric wards at Netcare Unitas and St. Anne`s hospitals were also refurbished. In conjunction with our empowerment partners, the construction of the 132-bed private hospital in Waterfall, Midrand, is progressing well and we anticipate its opening in July 2011. The construction of the 425-bed Lesotho Hospital, part of the Lesotho Public Private Partnership (PPP), remains on track and is scheduled to open in October 2011. The three primary care clinics that form part of the overall PPP delivery model are performing at expected levels with very good clinical outcomes. Primary Care The division continued its return to profitability. Revenue decreased by 7.4% to R628 million (2010: R678 million), mainly due to a 22.4% contraction in managed care lives in Prime Cure. Operating profit improved to R8 million from the R5 million operating loss in the prior period. This was due to stringent cost control measures and a strategy to reduce the proportion of full risk lives under managed care. The division improved access to affordable primary healthcare services through its national footprint of `one stop` Medicross family medical and dental centres (Medicentres). In conjunction with the Prime Cure clinics, approximately 1.6 million patient visits were managed during the period. United Kingdom General Healthcare Group (GHG) experienced a difficult trading period characterised by severe recessionary pressures and proposals for far-reaching regulatory changes in the healthcare sector. As anticipated, recessionary pressures constrained privately funded caseload in both the Private Medical Insurance (PMI) and self-pay markets. A higher VAT rate also added to GHG`s costs, as it is unable to claim input VAT. However, GHG remains the leading private healthcare player in the UK, with its geographic presence and range of services providing a distinct competitive advantage in challenging conditions. Overall caseload grew 19.4% year-on-year, driven largely by growth in NHS activity through the Choose and Book (C&B) programme. However, growth in this market segment was tempered by NHS funding constraints and caution as the UK Department of Health seeks to clarify issues related to implementing its White Paper reforms. The recently acquired Abbey hospitals and our investment in the Transform cosmetic surgery business contributed to volume growth, but this was offset by volume decline as the NHS Independent Sector Treatment Centre (ISTC) contracts wind down. Case mix was also negatively affected by an increase in day-case surgery versus inpatient admissions. Revenue from the UK operations rose by 6.5% to GBP445.8 million (2010: GBP418.7 million) for the period. However, the fall in private volumes and the growing partnership between the private sector and the NHS through the higher volume, lower margin C&B programme has changed the business mix. This has resulted in an 18.2% decline in EBITDA to GBP90.1 million (2010: GBP110.1 million). Operating profit for the period of GBP55.9 million (2010: GBP79.2 million) was 29.4% lower, impacted by increased VAT costs as well as winding down of the profitable ISTC contracts. A major rationalisation process is underway to significantly reduce the cost base of the business with restructuring and redundancy costs of GBP4.3 million incurred in this period. Related cost savings will only materialise in the second half of the year. Financial expenses were adversely affected by a GBP5.4 million (2010: GBP3.0 million) non-cash charge, representing the ineffective portion of the movement in the fair value of the interest rate swaps. A tax benefit of GBP14.0 million was recognised at half-year, following a 1% reduction in the UK statutory company tax rate to 26%. Profit after tax amounted to GBP7.1 million (2010: GBP15.3 million). Capital expenditure including intangible assets amounted to GBP19.9 million compared to GBP14.3 million in the prior period. The business continues to invest in strategic projects that will yield future growth and maintain its market-leading hospital infrastructure and facilities. Net debt reduced by GBP20 million to GBP1 855 million from September 2010, reflecting the benefits of stringent working capital management. This was driven by improved cash collection processes introduced to manage the impact of the industry-wide shift in business mix to higher NHS caseload at longer payment cycles. Cash balances increased to GBP90 million from GBP80 million in the prior period. Following the sale of the hospital land and buildings at the BMI Duchy Hospital in Harrogate in January 2011, GBP11 million of debt was repaid. GHG successfully met all financial covenants with sufficient headroom relating to its UK debt facilities, which are without recourse to the SA operations. Outlook Netcare remains confident that the demand for private healthcare services at primary and tertiary levels will be sustained in SA over the medium and long term. Our capital investment in expansion will boost growth in SA. The fundamentals of the UK private healthcare sector remain sound and the proposed White Paper reforms are positive for the private sector in the long term. The success of the NHS C&B programme is expected to entrench the private healthcare sector as a key partner to the NHS in delivering national healthcare needs. GHG is well placed to play a significant role in this regard. In the short term, however, recessionary pressures in the UK economy are expected to prevail for at least the remainder of this year, constraining growth in the PMI and self-pay markets. Growth in C&B activity is expected to continue, although this may be disrupted by NHS funding pressures and the uncertainty around the White Paper reforms. Board and management changes Thevendrie Brewer was appointed as an independent non-executive director with effect from 24 January 2011. The Board welcomes Thevendrie and looks forward to her contribution. Lynelle Bagwandeen was appointed Company Secretary with effect from 1 March 2011, following the resignation of Bert Kok on 28 February 2011. The Board expresses its gratitude to Bert for his significant contribution to Netcare and welcomes Lynelle to the Group. Michael Sacks has advised the Board that he will be retiring as a non- executive director effective 30 September 2011. Declaration of interim dividend number 4 Notice is hereby given that interim dividend number 4 of 22.0 cents per ordinary share (2010: capital reduction out of share premium of 19.0 cents per ordinary share), has been declared for the six months ended 31 March 2011. In accordance with the provisions of STRATE, the electronic settlement and custody system used by the JSE Limited, the relevant dates for the dividend are as follows: Last day to trade cum dividend Friday, 15 July 2011 Trading ex dividend commences Monday, 18 July 2011 Record date Friday, 22 July 2011 Payment date Monday, 25 July 2011 Share certificates may not be dematerialised nor rematerialised between Monday, 18 July 2011 and Friday, 22 July 2011, both days inclusive. On Monday, 25 July 2011, the dividend will be electronically transferred to the bank accounts of all certificated shareholders where this facility is available. Where electronic funds transfer is either not available or not elected by the shareholder, cheques dated Monday, 25 July 2011 will be posted on that date. Holders of dematerialised shares will have their accounts credited at their participant or broker on Monday, 25 July 2011. On behalf of the Board Jerry Vilakazi Chairman Richard Friedland Chief Executive Officer Vaughan Firman Chief Financial Officer Sandton 12 May 2011 Group statement of financial position Unaudited Unaudited Audited 31 Mar 31 Mar 30 Sep Rm Note 2011 2010 2010 Assets Non-current assets Property, plant and equipment 23 534 23 538 23 852 Goodwill 13 057 13 235 13 153 Intangible assets 324 337 331 Associated companies, investments and loans 2 249 182 180 Financial asset - Derivative financial instruments 13 26 Deferred taxation 1 071 1 040 1 446 Total non-current assets 38 248 38 332 38 988 Current assets Investments and loans 2 45 52 45 Financial asset - Derivative financial instruments 8 6 Inventories 689 677 652 Trade and other receivables 3 322 3 661 3 290 Cash and cash equivalents 1 384 1 094 1 378 5 448 5 484 5 371 Assets held for sale 3 8 6 13 Total current assets 5 456 5 490 5 384 Total assets 43 704 43 822 44 372 Equity and liabilities Capital and reserves Ordinary share capital and premium 577 819 624 Treasury shares (741) (767) (767) Option premium on convertible bond 164 169 164 Other reserves 104 (11) (496) Retained earnings 4 968 3 966 4 632 Equity attributable to owners of the parent 5 072 4 176 4 157 Preference share capital and premium 644 644 644 Non-controlling interest 2 297 2 177 1 728 Total shareholders` equity 8 013 6 997 6 529 Non-current liabilities Long-term debt 21 199 23 613 21 630 Financial liability - Derivative financial instruments 2 579 2 739 4 113 Post-retirement benefit obligations 182 288 179 Deferred lease liability 49 119 122 Deferred taxation 4 235 4 617 4 430 Provisions 32 39 30 Total non-current liabilities 28 276 31 415 30 504 Current liabilities Trade and other payables 3 173 2 841 3 118 Short-term debt 3 807 1 920 3 852 Taxation payable 219 226 276 Bank overdrafts 216 423 93 Total current liabilities 7 415 5 410 7 339 Total equity and liabilities 43 704 43 822 44 372 Group income statement Audited Unaudited year six months ended ended % 30 Sep
change 2010 31 Mar 31 Mar
Rm Note 2011 2010 Revenue 11 392 11 038 3.2 22 474 Cost of sales (6 681) (6 404) (12 893) Gross profit 4 711 4 634 1.7 9 581 Other income 177 118 255 Administrative and other expenses (3 190) (2 909) (6 128) Operating profit 4 1 698 1 843 (7.9) 3 708 Financial income 5 26 24 106 Financial expenses 6 (974) (1 029) 5.3 (2 084) Attributable earnings of associates 3 16 24 Profit before taxation 753 854 (11.8) 1 754 Taxation (54) (185) (294) Profit for the period 699 669 4.5 1 460 Attributable to: Owners of the parent 642 551 1 233 Preference shareholders 24 28 53 Profit attributable to shareholders 666 579 1 286 Non-controlling interest 33 90 174 699 669 1 460 Earnings per share (cents) Basic 50.2 43.4 15.7 97.0 Diluted 48.7 41.8 16.5 94.6 Distributions per share (cents) Capital reduction 19.0 25.5 Dividend 22.0 21.0 22.0 19.0 15.8 46.5 Group statement of comprehensive income Audited
Unaudited year six months ended ended 30 Sep 2010
31 Mar 31 Mar Rm Note 2011 2010 Profit for the period 699 669 1 460 Other comprehensive income/(loss), net of tax 1 089 (540) (1 519) Actuarial gains on defined benefit plans 29 Effect of cash flow hedge accounting Change in the fair value of cash flow hedges 1 130 (129) (1 118) Recycling of cash flow hedge 5 & 6 accounting reserve (net) 1 (5) (10) Effect of translation of foreign entities (42) (406) (420) Total comprehensive income/(loss) for the period 1 788 129 (59) Attributable to: Owners of the parent 1 209 268 441 Preference shareholders 24 28 53 Non-controlling interest 555 (167) (553) 1 788 129 (59)
Headline earnings Unaudited Audited six months ended year ended % 30 Sep
Rm change 2010 31 Mar 31 Mar 2011 2010
Reconciliation of headline earnings Profit for the period 699 669 4.5 1 460 Less: Preference shareholders (24) (28) (53) Non-controlling interest (33) (90) (174) Earnings used in the calculation of basic earnings per share 642 551 16.5 1 233 Adjusted for: Impairment of goodwill 9 Impairment of investments 8 Impairment of property, plant and equipment 19 Reversal of impairment of property, plant and equipment (1) (1) (1) (Profit)/loss on disposal of property, plant and equipment (55) (1) 1 Gain on bargain purchase (44) (81) Tax effect of headline adjusting items 8 Non-controlling share of headline adjusting items 19 22 38 Headline earnings 613 527 16.3 1 226 Headline earnings per share (cents) Basic 48.0 41.5 15.7 96.5 Diluted 46.5 40.0 16.3 94.1 Group statement of cash flows Unaudited Audited six months ended
year ended 31 Mar 31 Mar 30 Sep Rm 2011 2010 2010 Cash flows from operating activities Cash received from customers 11 349 10 664 22 518 Cash paid to suppliers and employees (9 365) (8 770) (17 584) Cash generated from operations 1 984 1 894 4 934 Interest paid (902) (993) (1 981) Taxation paid (346) (302) (565) Capital reductions paid (83) (279) (521) Ordinary dividends paid (269) Ordinary dividends paid by subsidiaries (1) (1) (1) Preference dividends paid (24) (28) (53) Distributions to beneficiaries of the HPFL Trusts (38) Net cash from operating activities 321 291 1 813 Cash flows from investing activities Purchase of property, plant and equipment (436) (423) (1 284) Proceeds on disposal of property, plant and equipment 144 46 19 Additions to intangible assets (25) (26) (86) Decrease/(increase) in investments and loans 85 (34) (29) Additions to derivatives (32) Interest received 26 18 93 Dividends received 1 2 Increase in equity interest in subsidiaries (2) Acquisition of subsidiaries and businesses, net of cash acquired (19) 21 Net cash from investing activities (206) (437) (1 298) Cash flows from financing activities Proceeds from issue of ordinary shares 36 33 80 Proceeds on disposal of treasury shares 62 Long-term liabilities (repaid)/raised (286) 2 883 Short-term liabilities (repaid)/raised (37) 128 (825) Net cash from financing activities (225) 163 138 Net (decrease)/increase in cash and cash equivalents (110) 17 653 Translation effects on cash and cash equivalents of foreign entities (7) (60) (82) Cash and cash equivalents at beginning of the period 1 285 714 714 Cash and cash equivalents at end of the period 1 168 671 1 285 Consisting of: Cash on hand and balances with banks 1 384 1 094 1 378 Short-term money market borrowings and bank overdrafts (216) (423) (93) 1 168 671 1 285 Group statement of changes in equity Ordinary share Option capital premium on and Treasury convertible
Rm premium shares bond Balance at 30 September 2009 1 065 (767) 169 Shares issued during the period 33 Capital reduction (279) Share-based payments reserve movements Other reserve movements Preference dividends paid Dividends paid by subsidiaries Total comprehensive income for the period Balance at 31 March 2010 819 (767) 169 Shares issued during the period 47 Capital reduction (242) Repurchase of convertible bond (5) Share-based payments reserve movements Other reserve movements Capital gains tax on capital reductions attributable to treasury shares Preference dividends paid Acquisition of shares in subsidiary Total comprehensive income for the period Balance at 30 September 2010 624 (767) 164 Shares issued during the period 36 Capital reduction (83) Disposal of treasury shares 26 Share-based payments reserve movements Other reserve movements Capital gains tax on capital reductions attributable to treasury shares Preference dividends paid Dividends paid Dividends paid by subsidiaries Distributions to beneficiaries of the HPFL Trusts Total comprehensive income for the period Balance at 31 March 2011 577 (741) 164 Foreign currency Cash flow translation Other
Rm hedge reserve reserves Balance at 30 September 2009 (1 216) 976 471 Shares issued during the period Capital reduction Share-based payments reserve 12 movements Other reserve movements 29 Preference dividends paid Dividends paid by subsidiaries Total comprehensive income for the period (66) (217) Balance at 31 March 2010 (1 282) 759 512 Shares issued during the period Capital reduction Repurchase of convertible bond Share-based payments reserve 14 movements Other reserve movements 25 Capital gains tax on capital reductions attributable to treasury shares Preference dividends paid Acquisition of shares in subsidiary Total comprehensive income for the period (508) (16) Balance at 30 September 2010 (1 790) 743 551 Shares issued during the period Capital reduction Disposal of treasury shares Share-based payments reserve 14 movements Other reserve movements 19 Capital gains tax on capital reductions attributable to treasury shares Preference dividends paid Dividends paid Dividends paid by subsidiaries Distributions to beneficiaries of the HPFL Trusts Total comprehensive income for the period 588 (21) Balance at 31 March 2011 (1 202) 722 584 Equity Preference
Retained Rm earnings attributable share to owners capital and
of the parent premium Balance at 30 September 2009 3 446 4 144 644 Shares issued during the 33 period Capital reduction (279) Share-based payments reserve 12 movements Other reserve movements (31) (2) Preference dividends paid (28) (28) Dividends paid by subsidiaries Total comprehensive income for the period 579 296 Balance at 31 March 2010 3 966 4 176 644 Shares issued during the period 47 Capital reduction (242) Repurchase of convertible bond 2 (3) Share-based payments reserve movements 14 Other reserve movements (26) (1) Capital gains tax on capital reductions attributable to treasury shares (7) (7) Preference dividends paid (25) (25) Acquisition of shares in subsidiary Total comprehensive income for the period 722 198 Balance at 30 September 2010 4 632 4 157 644 Shares issued during the period 36 Capital reduction (83) Disposal of treasury shares 36 62 Share-based payments reserve movements 14 Other reserve movements (28) (9) Capital gains tax on capital reductions attributable to treasury shares (7) (7) Preference dividends paid (24) (24) Dividends paid (269) (269) Dividends paid by subsidiaries Distributions to beneficiaries of the HPFL Trusts (38) (38) Total comprehensive income for the period 666 1 233 Balance at 31 March 2011 4 968 5 072 644 Non- Total
controlling shareholders` Rm interest equity Balance at 30 September 2009 2 345 7 133 Shares issued during the period 33 Capital reduction (279) Share-based payments reserve movements 12 Other reserve movements (2) Preference dividends paid (28) Dividends paid by subsidiaries (1) (1) Total comprehensive income for the period (167) 129 Balance at 31 March 2010 2 177 6 997 Shares issued during the period 47 Capital reduction (242) Repurchase of convertible bond (3) Share-based payments reserve movements 14 Other reserve movements (1) Capital gains tax on capital reductions attributable to treasury shares (7) Preference dividends paid (25) Acquisition of shares in subsidiary (63) (63) Total comprehensive income for the period (386) (188) Balance at 30 September 2010 1 728 6 529 Shares issued during the period 36 Capital reduction (83) Disposal of treasury shares 62 Share-based payments reserve movements 14 Other reserve movements 15 6 Capital gains tax on capital reductions attributable to treasury shares (7) Preference dividends paid (24) Dividends paid (269) Dividends paid by subsidiaries (1) (1) Distributions to beneficiaries of the HPFL trusts (38) Total comprehensive income for the period 555 1 788 Balance at 31 March 2011 2 297 8 013 Notes 1. Basis of preparation and accounting policies The interim financial information for the six months ended 31 March 2011 has been prepared in accordance with the measurement and recognition criteria of International Financial Reporting Standards (IFRS) and complies with IAS 34 Interim Financial Reporting, the Listings Requirements of the JSE Limited and the Companies Act of South Africa. The accounting policies applied in the preparation of the interim financial statements are consistent with those applied for the year ended 30 September 2010, except for the adoption of Improvements to International Financial Reporting Standards 2010 (certain improvements have been adopted earlier than required). The implementation of these changes had no impact on the financial position or performance of the Group. Unaudited Audited six months ended year ended 31 Mar 31 Mar 30 Sep
2011 2010 2010 Rm 2. Associated companies, investments and loans Non-current Associated companies* 224 149 151 Available-for-sale investments 22 22 22 Other loans 3 11 7 249 182 180 Current Loans 45 52 45 294 234 225 * Directors` valuation of associated companies 412 304 369
3. Assets held for sale Certain land and buildings were classified as held for sale. No reversal of impairment was recognised in the current year (March and September 2010: R1 million). 8 6 13
4. Operating profit After charging: Depreciation and amortisation 568 557 1 157 Operating lease charges 176 199 420 5. Financial income Dividends received 1 2 Foreign exchange gains (net) 1 Interest received 26 18 93 Recycling of cash flow hedge 5 10 accounting reserve (net) 26 24 106
6. Financial expenses Fair value loss on financial asset 7 Foreign exchange losses (net) 1 Ineffectiveness recognised in the income statement arising from cash flow hedges (net) 61 36 103 Interest paid 904 993 1 981 Recycling of cash flow hedge accounting reserve (net) 1 974 1 029 2 084 7. Commitments Capital commitments 1 433 745 1 392 South Africa 1 310 461 1 213 United Kingdom 123 284 179 Operating lease commitments 3 089 3 090 3 048 South Africa 1 151 1 312 1 212 United Kingdom 1 938 1 778 1 836 8. Contingent liabilities (guarantees and surety ships) South Africa 669 656 645 United Kingdom 13 682 656 645 Condensed segment report The Group operates in two geographical regions, South Africa (SA) and the United Kingdom (UK). SA has two further segments, Hospital and Emergency services and Primary Care, which are separately monitored for decision-making purposes. The UK segment results are impacted by fluctuations in the Rand relative to the Pound Sterling on translation. The impact of foreign currency fluctuations were removed from the UK segment for decision-making purposes. Unaudited % Audited six months ended change
year ended 31 Mar 31 Mar 30 Sep Rm 2011 2010 2010 Income statement Revenue South Africa 6 472 6 014 7.6 12 541 Hospitals and Emergency services 5 844 5 336 9.5 11 167 Primary Care 628 678 (7.4) 1 374 United Kingdom 4 920 5 024 (2.1) 9 933 UK adjusted1 5 349 5 024 6.5 9 933 Exchange rate impact (429) Group reported 11 392 11 038 3.2 22 474 Exchange rate impact 429 Group adjusted1 11 821 11 038 7.1 22 474 EBITDA South Africa 1 212 1 035 17.1 2 249 Hospitals and Emergency services 1 191 1 029 15.7 2 220 Primary Care 21 6 250.0 29 United Kingdom 998 1 319 (24.3) 2 571 UK adjusted1 1 081 1 319 (18.0) 2 571 Exchange rate impact (83) Capital items 56 46 21.7 45 South Africa 9 1 (34) UK adjusted1 52 45 79 Exchange rate impact (5) Group reported 2 266 2 400 (5.6) 4 865 Exchange rate impact 88 Group adjusted1 2 354 2 400 (1.9) 4 865 Operating profit South Africa 1 021 849 20.3 1 899 Hospitals and Emergency services 1 013 854 18.6 1 893 Primary Care 8 (5) 260.0 6 United Kingdom 621 948 (34.5) 1 764 UK adjusted1 670 948 (29.3) 1 764 Exchange rate impact (49) Capital items 56 46 21.7 45 South Africa 9 1 (34) UK adjusted1 52 45 79 Exchange rate impact (5) Group reported 1 698 1 843 (7.9) 3 708 Exchange rate impact 54 Group adjusted1 1 752 1 843 (4.9) 3 708 Net interest expense South Africa 162 200 19.0 367 United Kingdom 716 775 7.6 1 521 UK adjusted1 780 775 (0.6) 1 521 Exchange rate impact (64) Group reported 878 975 9.9 1 888 Exchange rate impact 64 Group adjusted1 942 975 3.4 1 888 Statement of financial position Debt net of cash South Africa 3 713 4 212 11.8 3 706 United Kingdom 20 125 20 650 2.5 20 491 UK adjusted1 20 459 20 650 0.9 20 491 Exchange rate impact (334) Group reported 23 838 24 862 4.1 24 197 Exchange rate impact 334 Group adjusted1 24 172 24 862 2.8 24 197 1 The March 2011 UK numbers have been recalculated to remove the impact of foreign currency fluctuations since the March 2010 results. Salient features Unaudited Unaudited Audited 31 Mar 31 Mar 31 Mar
2011 2010 2010 Share statistics Ordinary shares Shares in issue net of treasury shares (million) 1 277 1 271 1 277 Weighted average number of shares (million) 1 279 1 269 1 271 Diluted weighted average number of shares (million) 1 318 1 318 1 303 Market price per share (cents) 1 450 1 320 1 384 Currency conversion guide (R:GBP) Closing exchange rate 10.85 11.03 10.93 Average exchange rate for the period 11.02 12.00 11.63 Registered office: 76 Maude Street (corner West Street), Sandton 2196,Private Bag X34, Benmore, 2010 Executive RH Friedland (Chief Executive Officer), directors: VE Firman (Chief Financial Officer),VLJ Litlhakanyane Non-executive SJ Vilakazi (Chairman), T Brewer, APH Jammine, directors: JM Kahn, MJ Kuscus, HR Levin, KD Moroka, MI Sacks, N Weltman Company Secretary: L Bagwandeen Sponsor: Nedbank Capital, a division of Nedbank Group Limited
Transfer Link Market Services (Proprietary) Limited, secretaries: 11 Diagonal Street, Johannesburg, 2001 Investor relations: ir@netcare.co.za; www.netcareinvestor.co.za Date: 16/05/2011 07:05:14 Supplied by www.sharenet.co.za Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on, information disseminated through SENS.

Share This Story